The enFuse, developed and manufactured by Enable Injections, is designed to enable user-administered subcutaneous delivery of high-volume therapeutics outside of a healthcare facility. The enFuse is a platform of wearable devices designed to enable subcutaneous self-administration of high-volume therapeutics. The enFuse platform, developed and manufactured by Enable Injections, is designed to provide a multitude of options to easily transfer drugs from any standard container closure to the enFuse. Enable’s device platform can be developed for use with small molecule and biologic drug formulations across a range of viscosities. Watch our enFuse brand video at our website.
Enable Injections
Unlock to Claim this listing
Add / Modify Company
Click to rate this company
[Total: 0 Average: 0]
You must sign in to vote
3.2
Overall Excellence Rating
Industry
HealthcareCategory
Biotech & PharmaceuticalsESG/Ethical Impact
Inovative Drug Delivery: Enable Injections’ focus on wearable devices for drug delivery could lead to more efficient and targeted drug administration, potentially reducing waste associated with traditional methods. Material Selection: The company might prioritize eco-friendly and sustainable materials in its device manufacturing to minimize environmental impact. Collaboration: Enable Injections could collaborate with partners and suppliers to promote sustainable practices within the medical device industry.Enable Injections’ wearable devices aim to improve patient comfort and compliance, enhancing overall treatment experiences. Healthcare Access: The company’s technology could provide more accessible and user-friendly options for patients requiring frequent drug administration.Enable Injections’ governance structure likely includes a leadership team responsible for strategic decisions and ethical practices. Ethical Device Development: The company may uphold high ethical standards in the design, development, and testing of its drug delivery devices, ensuring patient safety and regulatory compliance. Enable Injections could prioritize transparent communication with stakeholders about its technology, regulatory approvals, and ethical considerations.Enable Injections’ ESG efforts could contribute to its long-term financial success by enhancing its reputation, attracting responsible investors, and improving operational efficiency. Innovation: The company’s wearable drug delivery devices might lead to breakthroughs in patient-centered healthcare solutions, increasing market value and growth potential. Investor Confidence: Strong ESG performance can attract investors who prioritize companies with responsible and ethical business practices.Enable Injections’ commitment to patient safety ensures that its wearable devices adhere to rigorous ethical and safety standards. Data Security: The company’s operations likely prioritize data security and privacy, especially given the potential connectivity of wearable medical devices.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.
Awards Received
2023
Revenues
$14,200,000.00
Website Traffic
Employee Rating
4
Customer Rating
4
Company Size
100-1000
ESG Risk Rating
3
We’re Happy to Help.
Do you have questions about your ranking, our projects, or why you’re not on the list?